Literature DB >> 794412

H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D.

R M Zinkernagel, R M Welsh.   

Abstract

Adoptive immunization of recipient mice preinfected with lymphocytic choriomeningitis virus (LCMV) is mediated exclusively by virus-specific thymus-derived lymphocytes, when assayed in a short-term transfer model. Protection, measured as reduction of LCMV plaque-forming units in spleens, is conferred only if donors of immune spleen cells and recipients share the K or the D region of the H-2 gene complex. I region compatibility is neither necessary nor sufficient. The F1 leads to Parent combination is as effective as a syngeneic system. Admixture of a 6-fold excess of immune allogeneic cells did not impair the protective effect exerted by syngeneic immune spleen cells in vivo. Furthermore, allogeneic spleen cells or target cells added in syngeneic systems in vitro did not allogeneicly inhibit or suppress cytolytic activity. H-2 mutant mice B6. H-2bf did not protect wild type H-2Kb B10.A(5r) or vice versa. Therefore, these mice define the gene(s) coding for the relevant cell-surface structure involved. These results are consistent with the idea that immune T cells, which are specific for virally altered cell-surface self structures impair virus growth in vivo either by lysing target cells, probably before infectious virus is released, or alternatively via activities exerted by lymphokines.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 794412

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

1.  Rotavirus-specific cytotoxic T lymphocytes cross-react with target cells infected with different rotavirus serotypes.

Authors:  P A Offit; K I Dudzik
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

2.  Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection.

Authors:  K E Wright; M J Buchmeier
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

3.  Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs.

Authors:  M J Reddehase; F Weiland; K Münch; S Jonjic; A Lüske; U H Koszinowski
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

4.  Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. III. In vivo protective activity of effector cells generated in vitro.

Authors:  M B Dunlop
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

5.  Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene.

Authors:  R Finberg; H L Weiner; B N Fields; B Benacerraf; S J Burakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

6.  Genetic analysis of in vivo-selected viral variants causing chronic infection: importance of mutation in the L RNA segment of lymphocytic choriomeningitis virus.

Authors:  R Ahmed; R S Simon; M Matloubian; S R Kolhekar; P J Southern; D M Freedman
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

7.  Therapeutic depletion of natural killer cells controls persistent infection.

Authors:  Stephen N Waggoner; Keith A Daniels; Raymond M Welsh
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

8.  Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation.

Authors:  Patrick Lacasse; Jérôme Denis; Réjean Lapointe; Denis Leclerc; Alain Lamarre
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

9.  Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence.

Authors:  M Salvato; P Borrow; E Shimomaye; M B Oldstone
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

10.  Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8.

Authors:  Fabiola Micheletti; Paolo Monini; Cinzia Fortini; Paola Rimessi; Martina Bazzaro; Massimo Andreoni; Massimo Giuliani; Serena Traniello; Barbara Ensoli; Riccardo Gavioli
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.